The Efficacy and Toxicity of Neoadjuvant Chemotherapy Regimens of Epirubicin Plus Cyclophosphamide Followed by Docetaxel or Paclitaxel in Female Breast Cancer Patients

PURPOSE: To retrospectively analyze the efficacy and toxicity of epirubicin plus cyclophosphamide followed by docetaxel (EC-D) and epirubicin plus cyclophosphamide followed by paclitaxel (EC-P) efficacy as neoadjuvant chemotherapy regiments by pathological complete response (pCR) in this study. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xian, Ye, Chaoran, Wang, Xingmeng, Cai, Ruyu, Yang, Junzhe, Yu, Xiafei, Zhou, Yi, Shen, Li, Zhu, Yanhui, Liu, Xiaoan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894818/
https://www.ncbi.nlm.nih.gov/pubmed/33623431
http://dx.doi.org/10.2147/CMAR.S284638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894818/
https://www.ncbi.nlm.nih.gov/pubmed/33623431
http://dx.doi.org/10.2147/CMAR.S284638

Ejemplares similares